chris kresser glp-1 RHR: The Blind Spot: What Ozempic Won't Do for Your Metabolic Health GLP-1 Agonists and Hormone Health:
Description
GLP-1 medications prescribing trends from 20182024 reveal shifts in semaglutide and tirzepatide use for type 2 diabetes and obesity.
Read on to learn more about how we might be able to help.
Important update for our community The White House recently announced that TrumpRX will be lowering the cost of brand-name Ozempic and Wegovy to $350/month
Bad breath can develop during GLP-1 therapy, but it's usually manageable with simple oral hygiene adjustments
From 2016 through 2022, the utilization of transitional assistance has steadily increased from 41% to 56% of all commercial claims
